Quantcast
Home > Quotes > NNVC

NanoViricides, Inc. Common Stock (NNVC) Quote & Summary Data

NNVC 
$5.68
*  
0.11
1.97%
Get NNVC Alerts
*Delayed - data as of Mar. 27, 2020  -  Find a broker to begin trading NNVC now
Exchange:AMEX
Industry: Health Care
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
Today's High / Low
$ 6 / $ 5.2805
Share Volume
418,848
90 Day Avg. Daily Volume
3,018,023
Previous Close
$ 5.57
52 Week High / Low
$ 19.20 / $ 1.2713
Market Cap
42,162,640
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1

Intraday Chart

Shares Traded

Share Volume:
418,848
90 Day Avg. Daily Volume:
3,018,023

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -2.21

Trading Range

The current last sale of $5.68 is 346.79% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 6 $ 19.20
 Low: $ 5.2805 $ 1.2713

Company Description (as filed with the SEC)

NanoViricides, Inc. (the "Company," "we," or "us") was incorporated in Nevada on April 1, 2005. Our corporate offices are located at 1 Controls Drive, Shelton, Connecticut 06484 and our telephone number is (203) 937-6137. Our Website is located at http://www.Nanoviricides.com. We do not incorporate by reference into this Annual Report the information on or accessible through our website, and you should not consider it part of this Annual Report. On September 25, 2013, the Company's common stock began trading on the New York Stock Exchange American under the symbol, "NNVC". We are a development stage company with several drugs in various stages of pre-clinical development, including late stage IND-enabling non-clinical studies. We have no customers, products or revenues to date, and may never achieve revenues or profitable operations.  ... More ...  



Risk Grade

Where does NNVC fit in the risk graph?


Risk Grade Scale



Consensus Recommendation

Analyst Info